Abstract
Virus replication is the result of a series of two-way communications between the viral parasite and its host. Since viruses are essentially inert objects in the absence of a host cell, all aspects of their natural history can be defined in terms of these interactions. For example, whether or not a cell is permissive to infection and subsequent virus replication, or whether non-productive infection results, is determined by the expression of specific cellular factors which are necessary for each stage in the viral life cycle. In turn, the virus may modulate or enhance the expression of these factors to suit its particular needs. Viral tropism is then similarly determined through these interactions, since the presence of the viral receptor molecule on a cell is only the first requisite for productive infection. The pathogenicity of a virus is also clearly the result of these interactions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aguanno S, Bouche M, Adamo S, Molinaro M (1990) 12-O-Tetradecanoylphorbol-13-acetate-induced differentiation of a human rhabdomyosarcoma cell Line. Cancer Res 50: 3377–3382
Arrigo SJ, Chen ISY (1991) Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev 5: 808–819
Balliet JW, Kolson DL, Eiger G, Kim FM, McGann KA, Srinivasan A, Collman R (1994) Distinct effect in primary macrophages and lymphocytes of the human immunodeficiency virus typw 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary isolate. Virology 200: 623–631
Balotta C, Lusso P, Crowley R, Gallo RC, Franchini G (1993) Antisense phosphorothioate oligodeoxy-nucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. J Virol 67: 4409–4414
Barre-Sinoussi F, Cherman JC, Rey F, Nugeyre MT, Chameret S, Gruest J, Dauguet C, Axlerblin C, Brun-Ve’zinet F, Rauzioux C, Rozenbaum W and Montagnier L (1984) Isolation of a T-lymphotropic retro-virus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868–871
Bednarik DP, Folks TM (1992) Mechanisms of HIV-1 latency. AIDS 6: 3–16
Bednarik DRP, Mosca JD, Raj NBK (1987) Methylation as a modulator of expression of human immunodeficiency virus. J Virol 61: 1253–1257
Bukrinsky Ml, Stanwick TL, Dempsey MP, Stevenson M (1991) Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254: 423–427
Butera ST, Perez VL, Wu B-Y, Nabel GJ, Folks TM (1991) Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection. J Virol 65: 4645–4653
Clapham PR (1991) Human immunodeficiency virus infectin of non-haematopoietic cells: the role of CD4 independent entry. Med Virol 1: 51–58
Clapham PR, Weber JN, Whitby D, Mclntosh K, Gagleish AG, Maddon PJ, Deen KC, Sweet RW, Weiss RA (1989) Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T-cells and monocytes but not for brain and muscle cells. Nature 337: 368–370
Clapham PR, Blanc D, Weiss RA (1991) Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181: 703–715
Cohen EA, Dehni G, Sodroski JG, Haseltine WH (1990a) Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol 64: 3097–3099
Cohen EA, Terwilliger EF, Jalinoos Y, Proulx J, Sodroski JG, Haseltine WH (1990b) Identification of HIV-1 vpr product and function. J AIDS 3: 11–18
Cullen BR (1991) Human immunodeficiency virus as a prototypic complex retrovirus. J Virol 65: 1053–1056
Dahl KE, Burrage T, Jones F, Miller G (1990) Persistent nonproductive infection of Epstein-Barr virustransformed human B lymphocytes by human immunodeficiency virus type 1. J Virol 64: 1771–1783
Daniel MD, Desrosiers RC (1989) Use of simian immunodeficiency virus for evaluation of AIDS vaccine strategies. AIDS 3: S131–S133
Dedera D, Hu W, Vander Heyden N, Ratner L (1989) Viral protein R of human immunodeficiency virus types 1 and 2 is dispensible for replication and cytopathogenicity in lymphoid cells. J Virol 63: 3205–3208
Embretson J, Zupancic M, Beneke J, Till M, Wolinsky S, Ribas JL, Burke A, Haase AT (1993a) Analysis of human immunodeficiency virus-infected tissues by amplification of in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci USA 90: 357–361
Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner RK, Haase AT (1993b) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubatin period of AIDS. Nature (Lond) 362: 359–362
Felber BK, Pavlakis GN (1993) Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression. AIDS 7: S51–S62
Felix CA, Chavez Kappel C, Mitsudomi T, Nau MM, Tsokos M, Crouch GD, Nisen PD, Winick NJ, Helman LJ (1992) Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res 52: 2243–2247
Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS (1987) Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238: 800–802
Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci AS (1989) Tumor necrosis factor α induces expresssion of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 86: 2365–2368
Francini G, Rusche JR, O’Keeffe TJ, Wong-Staal F (1988) The human immunodeficiency virus type 2 (HIV-2) contains a novel gene encoding a 16 kD protein associated with mature virions. AIDS Res Hum Retroviruses 4: 243–249
Fukasawa M, Miura T, Hasegawa A, Morikawa S, Tsujimoto H, Miki K, Kitamura T, Hayami M (1988) Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature 333: 457–461
Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PA (1984) Human T-lymphotropic retrovirus, HTLV-III, isolated from AIDS patients and donors at risk for AIDS. Science 224: 500–503
Garrett ED, Tiley LS, Cullen BR (1991) Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J Virol 65: 1653–1657
Gazzolo L, Macé K (1990) Regulation of HIV-1 replication in promonocytic U937 cells. Res Virol 141: 259–265
Gendelman HE, Phelps W, Feigenbaum L, Ostrove JM, Adachi A, Howley PM, Khoury G, Ginsberg HS, Martin MA (1986) Transactivation of the human immunodeficiency virus long terminal repeat sequences by DNA viruses. Proc Natl Acad Sci USA 83: 9759–9763.
Gras-Masse H, Ameisen JC, Boutillon C, Gesquiere JC, Vian S, Neyrinck JL, Drobecq H, Capron A, Tartar A (1990) A synthetic protein corresponding to the entire vpr gene product from the human immunodeficiency virus HIV-1 is recognized by antibodies from HIV-infected patients. Int J Pept Protein Res 36: 219–26
Haggerty S, Dempsey MP, Bukrinsky MI, Guo L, Stevenson M (1991) Posttranslational modifications within the HIV-1 envelope glycoprotein which restrict virus assembly and CD4-dependent infection. AIDS Res Hum Retroviruses 7: 501–510
Hattori N, Michaels F, Fargnoli K, Marcon L, Gallo RC, Franchini G (1990) The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proc Natl Acad Sci USA 87: 8080–8084
Heinzinger HE, Bukrinsky Ml, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nodividing cells. Proc Natl Acad USA 91: 7311–7315
Hiti AL, Bogenmann E, Gonzales F, Jones PA (1989) Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas. Mol Cell Biol 9: 4722–4730
Kappes JC, Morrow CD, Lee SW, Jameson BA, Kent SB, Hood LE, Shaw GM, Hahn BH (1988) Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC. J Virol 62: 3501–3505
Kestler HW III, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651–662
Kitano K, Baldwin GC, Raines MA, Golde DW (1990) Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. Blood 76: 1980–1988
Lang SM, Weeger M, Stahl-Henning C, Coulibaly C, Hunsmann G, Müller J, Müller-Hermelink H, Fuchs D, Wachter H, Daniel MM, Desrosiers RC, Fleckenstein B (1993) Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol 67: 902–912
Lavallee C, Yao XJ, Ladha A, Gottlinger H, Haseltine WA, Cohen EA (1994) Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 particles. J Virol 68: 1926–1934
Levy DN (1994) Studies of HIV-1 Vpr PhD thesis, University of Pennsylvania, Philadelphia, PA
Levy DN, Weiner DB (1993) HIV regulatory gene function analysis in a rhabdomyosarcoma cell line. In: Ginsberb HS, Brown F, Chanock RM, Lerner RA Vaccines93: modern approaches to new vaccines including the prevention of AIDS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Levy DN, Fernandes LS, Williams WV, Weiner DB (1993) Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72: 541–550
Levy DN, Refaeli Y, MacGreggor RR, Weiner DB (1994) Serum vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 91: 10873–10877
Levy DN, Refaeli Y, Weiner DB (1995a) Extracellular vpr protein increases cellular permissiveness to HIV replication and reactivates virus from latency. J Virol (in press)
Levy DN, Refaeli Y, Weiner DB (1995b) (submitted for publication)
Levy JA (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57: 183–289
Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro LS (1984) Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225: 840–842
Lu Y-L, Spearman P, Ratner L (1993) Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol 67: 6542–6550
Marck C (1988) “DNA Strider”: a “C” program for the fast analysis of DNA and protein sequences on the Apple Macintosh family of computers. Nucleic Acids Res 16: 1829–1836
McCune JM (1991) HIV-1 the infectivity process in vivo. Cell 64: 351–363
Meylan PRA, Spina CA, Richman DD, Kombluth RS (1993) In vitro differentiation of monocytoid THP-1 cells affects their permissiveness for HIV strains: a model for studying the cellular basis of HIV differential tropism. Virology 193: 256–267
Mikovits JA, Raziuddin Gonda M, Ruta M, Lohrey NC, Kung H-F, Ruscetti FW (1990) Negative regulation of human immunodeficiency virus replication in monocytes. J Exp Med 171: 1705–1720
Mikovits JA, Lohrey NC, Schulof R, Courtlëss J, Ruscetti FW (1992) Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo. J Clin Invest 90: 1486–1491
Mosca JD, Bednarik DP, Raj NB, Rosen CA, Sodroski JG, Haseltine WA, Pitha PM (1987) herpes simplex virus type 1 can reactivate transcription of latent human immunodeficiency virus. Nature (Lond): 325: 67–70
Myers G, Korber B, Berzofsky JA, Smith RF, Pavlakis GN (1991) Hum Retroviruses AIDS III: 6–22
Ogawa K, Shibata R, Kiyomasu T, Higuchi I, Kishida Y, Ishimoto A, Adachi A (1989) Mutational analysis of the human immunodeficiency virus vpr open reading frame. J Virol 63: 4110–4114
Oldstone MBA (1991) Molecular anatomy of viral persistence. J Virol 65: 6381–6386
Pantaleo G, Graziosi C, Butini L, Pizzo PA, Schnittman SM, Kotler DP, Fauci AS (1991) Lymphoid organs function as major reserviors for human immunodeficiency virus. Proc Natl Acad Sci USA 88: 9838–9842
Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (Lond) 362: 355–358
Pautrat G, Suzan M, Salaun D, Corbreau P, Allasia C, Morel G, Filippi P (1990) Human immunodeficiency virus type 1 infection of U937 cells promotes cell differentiation and a new pathway of viral assembly. Virology 179: 749–758
Pavlakis GN, Schwartz S, D’Agostino DM, Felber BK (1992) Structure, splicing, and regulation of expression of HIV-1, a model for the general organization of lentiviruses and other complex retroviruses. In: AIDS Research Reviews, Vol. 2. Eds.: W.C. Koff, F. Wong-Staal, R.C. Kennedy, Marcel Dekker, Inc. N.Y., N.Y.
Paxton W, Connor Rl, Landau NR (1993) Incorporation of vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J Virol 67: 7229–7237
Perez VL, Rowe T, Justement JS, Butera ST, June CH, Folks TM (1991) An HIV-1 infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation. J Immunol 147: 3145–3148
Perno C-F, Yarchoan R, Cooney DA, Hartman NR, Webb DSA, Hao Z, Mitsuya H, Johns DG, Broder S (1989) Replication of human immunodificiency virus in monocytes. J Exp Med 169: 933–951
Pomerantz RJ, Trono D, Feinberg MB, Baltimore D (1990) Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61: 1271–1276
Refaeli Y, Levy DN, Weiner DB (1995) (submitted for publication)
Reiss P, Lange JM, de RA, de WF, Dekker J, Danner SA, Debouck C, Goudsmit J (1990) Antibody response to viral proteins U (vpu) and R(vpr) in HIV-1-infected individuals. J Acquir Immun Defic Syndr 3: 115–22
Rich EA, Chen ISY, Zack JA, Leonard ML, O’Brien WA (1992) Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 89: 176–183
Roulston A, D’Addario M, Boulerice F, Caplan S, Wainberg MA, Hiscott J (1992) Induction of monocytic differentiation and NF-KB-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells. J Exp Med 175: 751–763
Sato A, Igarashi H, Adachi A, Hayami M (1990) Identification and localization of vpr gene product of Human Immunodeficiency Virus Type 1. Virus Genes 4: 303–312
Schnittman SM, Psallidopoulos MC, Clifford Lane H, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, Fauci AS (1989) The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245: 305–308
Schuitemaker H, Kootstra NA, Koppelman MHGM, Bruisten SM, Huisman HG, Tersmette M, Miedema F (1992) Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 89: 1154–1160
Schüpbach J (1989) Human retrovirology. Facts and concepts. Springer, Berlin Heidelberg New York (Current Topics in Microbiology and immunology, vol 142)
Shibata R, Miura T Hayami M, Ogawa K, Sakai H, Kiyomasu T, Ishimoto A, Adachi A (1990) Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIVAGM. J Virol 64: 742–747
Siegel HN, Lukas RJ (1988) Morphological and Biochemical Differentiation of the Human Medulloblastoma Cell Line TE671. Dev Brain Res 44: 269–280
Silvennolnen O, Hure M (1990) Growth inhibition caused by serum depletion induces differentiation, interleukin 1 receptor expression and interleukin 1 responsiveness in the HL-60 promyelocytic leukemia cell line. Biochem Biophys Res Commun 168: 959–965
Srinivasan A, Goldsmith CS, York D, Anand R, Luciw P, Schochetman G, Palmer E, Bohan C (1988) Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells. Arch Virol 99: 21–30
Stratton MR, Darling J, Pilkington GJ, Lantos PL, Reeves BR, Cooper CS (1989) Characterization of the human cell line TE671. Carcinogenesis 10: 899–905
Tateno M, Gonzalez-Scarano F, Levy JA (1989) Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc Natl Acad Sci USA, 86: 4287–4290
Terwilliger EF (1992) The accessory gene functions of the primate immunity viruses. In: Koff WC, Wong-Staal F, Kennedy RC (eds) AIDS Research Reviews vol 2. Marcel Dekker, New York
Tristem M, Marshal C, Karpas A, Hill F (1992) Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J 11: 3405–3412
Tristem M, Marshal C, Karpas A, Petrik J, Hill F (1990) Origin of vpx in lentiviruses. [Letter]. Nature (Lond) 347: 341–342
Turpin JA, Vargo M, Meltzer MS (1992) Enhanced HIV-1 replication in retinoid-treated monocytes: retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. J Immunol 148: 2539–2546
Valentin A, Von Gegerfelt A, Matsuda S, Nilsson K, Åsjö B (1991) In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. J AIDS 4: 751–759
Weiss RA, Clapham PR, McClure MO, McKeating JA, McKnight A, Dalgleish AG, Sattentau QJ, Weber JN (1988) Human immunodeficiency viruses: Neutralization and receptors. J AIDS 1: 536–541
Werner A, Winskowsky G, Cichutek K, Norley SG, Kurth R (1990) Productive infection of both CD4+ and CD4- human cell lines with HIV-1, HIV-2 and SIVAGM. AIDS 6: 537–544
Westervelt P, Henkel T, Trowbridge DB, Orenstein J, Heuser J, Gendelman HE, Ratner L (1992) Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. J Virol 66: 3925–3931
Winslow BJ, Pomerantz RJ, Bagasra O, Trono D (1993) HIV-1 latency due to the site of proviral integration. Virology 196: 849–854
Wong-Staal F, Chanda PK, Ghrayeb J (1987) Human immunodeficiency virus: the eighth gene. AIDS Res Hum Retroviruses 3: 33–39
Yu XF, Ito S, Essex M, Lee TH (1988) A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature 335: 262–265
Yu XF, Yu QC, Essex M, Lee TH (1991) The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage. J Virol 65: 5088–5091
Yuan X, Matsuda Z, Matsuda M, Esex M, Lee T-H (1990) Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res Hum Retroviruses 6: 1265–1271
Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS (1990) HIV-1 entry into quiescent primary lymphocytes: moleuclar analysis reveals a labile, latent viral structure. Cell 61: 213–222
Zack JA, Haislip AM, Krogstad P, Chen ISY (1992) Incompletely reverse- transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retrovial life cycle. J Virol 66: 1717–1725
Zhao L-J, Mukherjee S, Narayan O (1994) Biochemical mechanism of HIV-1 vpr function. Specific interaction with a cellular protein. Chem 289: 18877–15832
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Levy, D.N., Refaeli, Y., Weiner, D.B. (1995). The vpr Regulatory Gene of HIV. In: Chen, I.S.Y., Koprowski, H., Srinivasan, A., Vogt, P.K. (eds) Transacting Functions of Human Retroviruses. Current Topics in Microbiology and Immunology, vol 193. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78929-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-78929-8_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78931-1
Online ISBN: 978-3-642-78929-8
eBook Packages: Springer Book Archive